194 related articles for article (PubMed ID: 24561179)
1. A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats.
Boonpawa R; Spenkelink A; Rietjens IM; Punt A
Biochem Pharmacol; 2014 May; 89(2):287-99. PubMed ID: 24561179
[TBL] [Abstract][Full Text] [Related]
2. Use of physiologically based kinetic (PBK) modeling to study interindividual human variation and species differences in plasma concentrations of quercetin and its metabolites.
Boonpawa R; Moradi N; Spenkelink A; Rietjens IM; Punt A
Biochem Pharmacol; 2015 Dec; 98(4):690-702. PubMed ID: 26441251
[TBL] [Abstract][Full Text] [Related]
3. Difference in absorption of the two structurally similar flavonoid glycosides, hyperoside and isoquercitrin, in rats.
Chang Q; Zuo Z; Chow MS; Ho WK
Eur J Pharm Biopharm; 2005 Apr; 59(3):549-55. PubMed ID: 15760736
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans.
Boonpawa R; Spenkelink A; Punt A; Rietjens IMCM
Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28218440
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism.
Silberberg M; Morand C; Manach C; Scalbert A; Remesy C
Life Sci; 2005 Nov; 77(25):3156-67. PubMed ID: 15979103
[TBL] [Abstract][Full Text] [Related]
6. Nondigestible saccharides suppress the bacterial degradation of quercetin aglycone in the large intestine and enhance the bioavailability of quercetin glucoside in rats.
Matsukawa N; Matsumoto M; Shinoki A; Hagio M; Inoue R; Hara H
J Agric Food Chem; 2009 Oct; 57(20):9462-8. PubMed ID: 19807098
[TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability of quercetin from different quercetin glycosides in dogs.
Reinboth M; Wolffram S; Abraham G; Ungemach FR; Cermak R
Br J Nutr; 2010 Jul; 104(2):198-203. PubMed ID: 20230651
[TBL] [Abstract][Full Text] [Related]
8. The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides.
Arts IC; Sesink AL; Faassen-Peters M; Hollman PC
Br J Nutr; 2004 Jun; 91(6):841-7. PubMed ID: 15182387
[TBL] [Abstract][Full Text] [Related]
9. Quercetin 3-O-beta-glucoside is better absorbed than other quercetin forms and is not present in rat plasma.
Morand C; Manach C; Crespy V; Remesy C
Free Radic Res; 2000 Nov; 33(5):667-76. PubMed ID: 11200097
[TBL] [Abstract][Full Text] [Related]
10. Respective bioavailability of quercetin aglycone and its glycosides in a rat model.
Morand C; Manach C; Crespy V; Remesy C
Biofactors; 2000; 12(1-4):169-74. PubMed ID: 11216481
[TBL] [Abstract][Full Text] [Related]
11. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats.
Hou YC; Chao PD; Ho HJ; Wen CC; Hsiu SL
J Pharm Pharmacol; 2003 Feb; 55(2):199-203. PubMed ID: 12631412
[TBL] [Abstract][Full Text] [Related]
12. Dietary flavonoids as antioxidants in vivo: conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma.
Terao J
J Med Invest; 1999 Aug; 46(3-4):159-68. PubMed ID: 10687310
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioavailability of the flavonol quercetin in humans.
Graefe EU; Derendorf H; Veit M
Int J Clin Pharmacol Ther; 1999 May; 37(5):219-33. PubMed ID: 10363620
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of quercetin from its aglycone and its glucorhamnoside rutin in lactating dairy cows after intraduodenal administration.
Gohlke A; Ingelmann CJ; Nürnberg G; Starke A; Wolffram S; Metges CC
J Dairy Sci; 2013 Apr; 96(4):2303-2313. PubMed ID: 23403185
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and modeling of quercetin and metabolites.
Chen X; Yin OQ; Zuo Z; Chow MS
Pharm Res; 2005 Jun; 22(6):892-901. PubMed ID: 15948033
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic metabolites of quercetin after intestinal administration of quercetin-3-glucoside and its aglycone in rats.
Nakamura T; Kinjo C; Nakamura Y; Kato Y; Nishikawa M; Hamada M; Nakajima N; Ikushiro S; Murota K
Arch Biochem Biophys; 2018 May; 645():126-136. PubMed ID: 29574052
[TBL] [Abstract][Full Text] [Related]
17. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin.
Manach C; Morand C; Texier O; Favier ML; Agullo G; Demigné C; Régérat F; Rémésy C
J Nutr; 1995 Jul; 125(7):1911-22. PubMed ID: 7616308
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of [2-(14)C]quercetin-4'-glucoside in rats.
Mullen W; Rouanet JM; Auger C; Teissèdre PL; Caldwell ST; Hartley RC; Lean ME; Edwards CA; Crozier A
J Agric Food Chem; 2008 Dec; 56(24):12127-37. PubMed ID: 19053221
[TBL] [Abstract][Full Text] [Related]
19. Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IM; Punt A
Arch Toxicol; 2013 Sep; 87(9):1709-23. PubMed ID: 23943240
[TBL] [Abstract][Full Text] [Related]
20. Vegetable flavonoids and cardiovascular disease.
Terao J; Kawai Y; Murota K
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():291-3. PubMed ID: 18296359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
